Array, Sequencing Firms to Benefit from $10M UK Tumor Profiling and Data Capture Initiative | GenomeWeb

By Justin Petrone

Affymetrix, Almac Diagnostics, and Oxford Gene Technology are among the firms that have been awarded funding to develop new approaches for tumor profiling and data capture.

The UK's Technology Strategy Board announced last week that it would provide £6 million ($9.7 million) for the R&D projects. Companies heading other funded projects include Aridhia Informatics, IDBS, Life Technologies, and Source BioScience.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.